EUVIMEDEUVIMED entdecken
Crossref

New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine

Andrea E Steuer iD, Linda Sutter, Christian Steuer iD, Thomas Kraemer iD

Drug Testing and Analysis · 2023-04 · 15 (4) · 426-443

DOI: 10.1002/dta.3430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 03.01.2023. Verfasst von Andrea E Steuer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Sodium Oxybate. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gamma‐hydroxybutyric acid (GHB) represents an important drug in clinical and forensic toxicology, particularly in the context of drug‐facilitated crimes. Analytically, GHB remains a major challenge given its endogenous occurrence and short detection window. Previous studies identified a number of potential interesting novel conjugates of GHB with carnitine, amino acids (AA, glutamate, glycine, and taurine), or fatty acids. As a basis for comprehensive studies on the suitability of these novel biomarkers, we developed and validated a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method in human urine. Additionally, already known markers 2,4‐dihydroxy butyric acid (2,4‐DHB), 3,4‐DHB, glycolic acid, succinic acid, succinylcarnitine, and GHB glucuronide were included. The method was fully validated according to (inter)national guidelines. Synthetic urine proved suitable as a surrogate matrix for calibration. Matrix effects were observed for all analytes with suppression effects of about 50% at QC LOW, and approximately 20% to 40% at QC HIGH, but with consistent standard deviation of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium OxybateHumansChromatography, LiquidAmino AcidsTandem Mass SpectrometryFatty AcidsHydroxybutyratesCarnitineBiomarkersGlycineTaurine

Stichwörter der Autor:innen

GHBLC-MS/MSamino acidscarnitineconjugates

Substanzen

4-hydroxybutyric acidSodium OxybateAmino AcidsFatty AcidsHydroxybutyratesCarnitineBiomarkersGlycineTaurine

Autor:innen und Institutionen

  • Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.

ORCID-Profile: Andrea E Steuer, Christian Steuer, Thomas Kraemer

Zitieren

APA

Steuer, A. E., Sutter, L., Steuer, C., & Kraemer, T. (2023). New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine. Drug Testing and Analysis, 15(4), 426-443. https://doi.org/10.1002/dta.3430

Vancouver

Steuer AE, Sutter L, Steuer C, Kraemer T. New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine. Drug Testing and Analysis. 2023;15(4):426-443. doi:10.1002/dta.3430

BibTeX
@article{Steuer2023,
  author = {Steuer, Andrea E and Sutter, Linda and Steuer, Christian and Kraemer, Thomas},
  title = {New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine},
  journal = {Drug Testing and Analysis},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {426--443},
  doi = {10.1002/dta.3430}
}
Kostenlos starten →